Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Mara Aspinall
AddedFeb 19, 2024
UpdatedMay 31, 2026
Mara Aspinall

Mara Aspinall

Board Member, GenePeeks

CrunchbaseLinkedIn

Mara Aspinall's Career

GenePeeks
GenePeeks

New York City, NY, US

Board Member· Board
On-Q-ity
On-Q-ity

Waltham, MA, US

Founder
OraSure Technologies
OraSure Technologies

Bethlehem, PA, US

Board Member· Board
BlueStone Venture Partners
BlueStone Venture Partners

Tucson, AZ, US

Co-Founder
Castle Biosciences
Castle Biosciences

Friendswood, TX, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Mara Aspinall's Career

GenePeeks
GenePeeks
Series A$28.8M302009New York City, NY, US
Board Member· Board

Leadership at GenePeeks

Lee M. SilverLee M. SilverCo-Founder
Anne MorrissAnne MorrissCo-Founder

Similar to GenePeeks

23andMe23andMeSunnyvale, CA, USGenetic Testingest. 200623andMeSunnyvale, CA, US · est. 2006

23andMe: A biotech firm offering direct-to-consumer genetic testing for ancestry and health predispositions.

Public · $1.1B816
On-Q-ity
On-Q-ity
Series B$31M302009Waltham, MA, US
Founder

Leadership at On-Q-ity

Dion MadsenDion MadsenBoard Member
Bruce BoothBruce BoothBoard Member
Dr Robert S Epstein \"Rob\"Dr Robert S Epstein \"Rob\"Board Member

Similar to On-Q-ity

OnCirc DiagnosticsOnCirc DiagnosticsBeverly Hills, CA, USCancer Diagnosticsest. 2009OnCirc DiagnosticsBeverly Hills, CA, US · est. 2009

Innovative cancer diagnostics biotech in Beverly Hills.

Pre-Seed · $500k30
BloodQBloodQOrinda, CA, USCancer Treatment, DiagnosticsBloodQOrinda, CA, US

BloodQ offers personalized cancer treatment through its innovative diagnostic platform analyzing circulating DNA.

Seed · $4.5M2
OncoHealthOncoHealthMountain View, CA, USDiagnostic Testingest. 2009OncoHealthMountain View, CA, US · est. 2009

OncoHealth: Innovating cancer detection with diagnostic testing and screening devices.

Pre-Seed · $3.5M1
OncocyteOncocyteIrvine, CA, USCancer Diagnosticsest. 2009OncocyteIrvine, CA, US · est. 2009

Oncocyte Corporation: A US-based molecular diagnostics firm, optimizing cancer care through accelerated diagnosis and treatment.

Public · $57.2M75
OraSure Technologies
OraSure Technologies
Public$136M8401987Bethlehem, PA, US
Board Member· Board

Leadership at OraSure Technologies

David ShulkinDavid ShulkinBoard Member
Michael CelanoMichael CelanoBoard Member
Eamonn HobbsEamonn HobbsBoard Member
Mike GauslingMike GauslingFounder
Carrie Eglinton MannerCarrie Eglinton MannerCEO
Charles PatrickCharles PatrickBoard Member
BlueStone Venture Partners
BlueStone Venture Partners
Investment FirmInvestment Firm92017Tucson, AZ, US
Co-Founder

Leadership at BlueStone Venture Partners

Tom NickoloffTom NickoloffCo-Founder

Similar to BlueStone Venture Partners

Blue Stone CapitalBlue Stone Capitalward area of Tokyo, Tokyo, JPest. 2015Blue Stone Capitalward area of Tokyo, Tokyo, JP · est. 2015

Blue Stone Capital: Japanese VC firm

Investment Firm6
Bluestone Investment PartnersBluestone Investment PartnersMcLean, VA, USBluestone Investment PartnersMcLean, VA, US

Bluestone, a private equity firm, specializes in investing in lower middle-market defense and government services.

Investment Firm13
Blue Bay VenturesBlue Bay VenturesMiddlesbrough, North Yorkshire, GBest. 2021Blue Bay VenturesMiddlesbrough, North Yorkshire, GB · est. 2021

Blue Bay Ventures: A financial services and venture capital firm.

Investment Firm6
Bluestein VenturesBluestein VenturesChicago, IL, USest. 2009Bluestein VenturesChicago, IL, US · est. 2009

Bluestein, a venture capital fund since 2009, invests in innovative food industry ventures for consumer health and wellness.

Investment Firm8
Castle Biosciences
Castle Biosciences
Public$354.3M5432008Friendswood, TX, US
Board Member· Board

Leadership at Castle Biosciences

G. Bradley ColeG. Bradley ColeBoard Member
Tiffany OlsonTiffany OlsonBoard Member
Dan BradburyDan BradburyBoard Member
Bonnie AndersonBonnie AndersonBoard Member
Garheng KongGarheng KongBoard Member
Mr. Derek J. MaetzoldMr. Derek J. MaetzoldFounder

Similar to Castle Biosciences

Predictive BiosciencesPredictive BiosciencesLexington, KY, USCancer Testsest. 2006Predictive BiosciencesLexington, KY, US · est. 2006

Predictive Biosciences develops molecular tests and technologies for cancer diagnosis and monitoring in the US.

Pre-Seed · $68.1M75
BiodesixBiodesixBoulder, CO, USDiagnostic Testsest. 2005BiodesixBoulder, CO, US · est. 2005

Biodesix, Inc.: A leading biotech firm providing data-driven diagnostic solutions and lab tests in the US.

Public · $390.3M245
Caris Life SciencesCaris Life SciencesIrving, TX, USCancer Diagnosticsest. 1996Caris Life SciencesIrving, TX, US · est. 1996

US-based Caris Life Sciences specializes in innovative biotech solutions for cancer diagnosis and treatment.

Public · $1.7B1.5k
Foundation MedicineFoundation MedicineCambridge, MA, USCancer Diagnosticsest. 2010Foundation MedicineCambridge, MA, US · est. 2010

Foundation Medicine, Inc.: A U.S. genomics firm specializing in personalized cancer diagnostic technology.

Public · $96.5M662

Mara Aspinall's Similar Executives & Operators

Chi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · DunamuWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoBrian KimBrian KimCo-Founder · Kakao

People Similar to Mara Aspinall

Andrew BensonAndrew BensonCo-Founder · Synbiotic HealthMaryrose SylvesterMaryrose SylvesterBoard Member · Foundation Fighting BlindnessSukumar NagendranSukumar NagendranBoard Member · Taysha Gene TherapiesManon CoxManon CoxCo-Founder · NextWaveBioJane GrossJane GrossBoard Member · aTyr PharmaIndu ParikhIndu ParikhCo-Founder · Biomarck Pharmaceuticals